Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today.
Net sales decreased 2.6% year-over-year to $10.1 billion. On an organic basis, sales fell 1.5%.
Net earnings remained relatively unchanged at $1.43 billion compared to the year-ago quarter. GAAP EPS rose 1.2% to $0.82 while adjusted EPS dropped 1% to $1.14.
For the full year of 2023, the company expects GAAP EPS of $3.14-3.18 and adjusted EPS of $4.42-4.46.
Jerash Holdings (US), Inc. (NASDAQ: JRSH) reported significantly improved financial results for the fiscal 2026…
Shares of Prospect Capital Corporation (PSEC) traded mixed to slightly positive in early trading on…
Waters Corporation (WAT) shares dropped 14.49% to $326.04 in early trading on Tuesday after the…
Universal Corp. (UVV) shares fell 10.72% to $51.62 in Tuesday trading after the global agriproducts…
Upwork Inc (UPWK) shares fell 4.76% to $17.89 in early trading on Tuesday after the…
Amkor (NASDAQ: AMKR) posted net sales of $1888 million. Amkor Q4 2025 earnings showed robust…